Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Kissei licenses KGT development and sales rights in Japan to GlaxoSmithKline

June 3, 2008

New agents for diabetes and other endocrine-related disorders reported in recent patents

June 3, 2008

PharmaIN and PNRI enter collaboration to study PGC GLP-1 in combination with Januvia

June 3, 2008

Repros Therapeutics releases findings from 1-year extension safety study of Proellex

June 3, 2008

Lipoxen reports phase I data for long-acting insulin candidate, SuliXen

June 2, 2008

Ark Therapeutics to commence pilot phase III Vitor trial in cancer cachexia

May 30, 2008

Phase III results reveal efficacy of ospemifene for vulvovaginal atrophy symptoms

May 29, 2008

Avanir reports positive outcome of pharmacokinetic study of Zenvia

May 28, 2008

AMAG and 3SBio enter development and commercialization agreement for ferumoxytol in China

May 28, 2008

DiaMedica announces last patient out for phase II DM-83 trial

May 27, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...